Valirx (VAL)

 

Latest News

ValiRx says European patent granted for VAL201

ValiRx said a patent (Anti-Androgen Peptides and Uses Thereof in Cancer Therapy) covering its lead therapeutic compoun...

European Patent Granted for Lead Compound VAL201

RNS Number: 2297R ValiRx PLC 08 December 2016 Va li R x P lc ("ValiRx" or "the Company") EUROPEAN PATENT GRANTED FOR LEAD THERAPEUTIC COMPOUND VAL201 London, UK ., 08 December 2016: ValiRx Plc (AIM: VAL), a life science company, which focuses on clinical stage cancer therapeutic development, taking proprietary & novel techn...

ValiRx loan draw down

ValiRx has drawn down the second tranche of its convertible loan facility with YA Global Master SPV Ltd for the amoun...

Convertible Loan Facility

RNS Number: 8716Q ValiRx PLC 02 December 2016 Va li R x P lc ("ValiRx" or "the Company" or "the Group") Convertible Loan Facility London, UK ., 02 December 2016: ValiRx Plc (AIM: VAL), a life science company, which focuses on clinical stage cancer therapeutic development, taking proprietary & novel technology for precision medicines towards commerci...

All News

DateHeadlineSource
08-12-16ValiRx says European patent granted for VAL201StockMarketWire
08-12-16European Patent Granted for Lead Compound VAL201RNS
02-12-16ValiRx loan draw downStockMarketWire
02-12-16Convertible Loan FacilityRNS
01-12-16ValiRx notes ValiSeek clinical development updateStockMarketWire
01-12-16ValiSeek Clinical Development UpdateRNS
30-11-16ValiRx Plc - ValiSeek Clinical Development UpdateBRR Media
29-11-16Quarterly Update on Clinical DevelopmentsRNS
03-11-16ValiSeek Clinical Development UpdateRNS
02-11-16ValiRx plc - Valiseek clinical development update BRR Media
28-10-16Corporate Video re Clinical Status Q4, 2016RNS
28-10-16ValiRX - Clinical Status Q4 2016BRR Media
25-10-16ValiRx issues patent updateStockMarketWire
25-10-16Patent UpdateRNS
13-10-16Holding(s) in CompanyRNS
13-10-16Holding(s) in CompanyRNS
13-10-16Update on Recent PresentationsRNS
12-10-16Result of General MeetingRNS
05-10-16CLN ConversionRNS
28-09-16Notice of GMRNS
27-09-16Half-year ReportRNS
27-09-16ValiRx - Half-year ReportBRR Media
26-09-16ValiRx selected for The Parliamentary Review 2016RNS
13-09-16Quarterly Update on Clinical DevelopmentsRNS
13-09-16ValiRx - Quarterly update on clinical developmentsBRR Media
09-09-16Valirx Plc to present at the SHARES Investor Evening in Edinburgh on 5th October 2016StockMarketWire
02-09-16Placing, issue of warrants & Convertible LoanRNS
19-08-16Valirx Plc to present at the Shares LIVE Show in London on 10th September 2016StockMarketWire
11-08-16ValiRx gives ValiSeek clinical development updateStockMarketWire
11-08-16ValiSeek Clinical Development UpdateRNS
11-08-16ValiRx Plc - ValiSeek clinical development updateBRR Media
04-08-16Issue of EquityRNS
29-07-16ValiRx - New Zealand Patent Grant AllowanceBRR Media
28-07-16ValiRx notes notification of NZ Patent Grant AllowanceStockMarketWire
28-07-16Notification of New Zealand Patent Grant AllowanceRNS
26-07-16ValiRx issues equity, discontinues Bracknor facilityStockMarketWire
26-07-16Issue of Equity and Bracknor Facility UpdateRNS
14-07-16ValiRx issues ValiSeek clinical development update StockMarketWire
14-07-16ValiSeek Clinical Development UpdateRNS
14-07-16ValiRx - ValiSeek Clinical Development UpdateBRR Media

RSS feeds

  • Editorial news feed for LSE:VAL Editorial
  • Regulatory news feed for LSE:VAL Regulatory